BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29983581)

  • 1. Sofosbuvir-daclatasvir improves hepatitis C virus-induced mixed cryoglobulinemia: Upper Egypt experience.
    Hassan AM; Osman HA; Mahmoud HS; Hassan MH; Hashim AA; Ameen HH
    Infect Drug Resist; 2018; 11():895-901. PubMed ID: 29983581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis.
    Saadoun D; Pol S; Ferfar Y; Alric L; Hezode C; Si Ahmed SN; de Saint Martin L; Comarmond C; Bouyer AS; Musset L; Poynard T; Resche Rigon M; Cacoub P
    Gastroenterology; 2017 Jul; 153(1):49-52.e5. PubMed ID: 28288791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
    Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
    Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive Impacts from Hepatitis C Virus Infection and Mixed Cryoglobulinemia on Complement Levels.
    Chang ML; Hu JH; Chen WT; Lin MS; Kuo CJ; Chen SC; Chien RN
    Dig Dis Sci; 2021 Jul; 66(7):2407-2416. PubMed ID: 32737636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed cryoglobulinemia and hepatitis C virus.
    Cacoub P; Fabiani FL; Musset L; Perrin M; Frangeul L; Leger JM; Huraux JM; Piette JC; Godeau P
    Am J Med; 1994 Feb; 96(2):124-32. PubMed ID: 7509124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are direct-acting antivirals safe and effective in hepatitis C virus-cryoglobulinemia? virological, immunological, and clinical data from a real-life experience.
    Passerini M; Schiavini M; Magni CF; Landonio S; Niero F; Passerini S; Croci AL; Bolis M; Scalzi V; Gubertini G; Ricci ED; Galli M; Rizzardini G
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1208-1215. PubMed ID: 30138160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of Cryoglobulinemia in Direct-Acting Antiviral-Treated Asian Hepatitis C Patients With Sustained Virological Responses: A 4-Year Prospective Cohort Study.
    Chang ML; Cheng JS; Chuang YH; Pao LH; Wu TS; Chen SC; Chang MY; Chien RN
    Front Immunol; 2022; 13():823160. PubMed ID: 35371039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentric and nationwide predictive study role of T cell sub-population in the prevalence and prognosis of cryoglobulinemia among genotype 4 chronic hepatitis C patients.
    Abdel-Samiee M; Youssef MI; Elghamry F; Bazeed M; Al-Shorbagy M; Shalaby H; Shabana H; Abdelsameea E; Lashin HES; El Zamek HMF; Esam T; Alwaseef MAA; Helmy HA; Almarshad F; Khalaf FA; Yossef BWA; Kassem A; Gabr BM; Abdelfattah A; S AboShabaan H; Aboufarrag GA; Omar MM; Bakeer MS; Imam MS; Ibrahim ES; Kamel SY; Allisy T; Mohammed OS; Farahat A; El-Khayat MM; Sekeen MAH; Zaher EM; Said A; Abuamer A; Elmahdi E
    J Med Virol; 2023 Dec; 95(12):e29248. PubMed ID: 38108641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study.
    Gragnani L; Piluso A; Urraro T; Fabbrizzi A; Fognani E; Petraccia L; Genovesi A; Giubilei L; Ranieri J; Stasi C; Monti M; Zignego AL
    Curr Drug Targets; 2017; 18(7):772-785. PubMed ID: 26853322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.
    Cacoub P; Ghillani P; Revelen R; Thibault V; Calvez V; Charlotte F; Musset L; Youinou P; Piette JC
    J Hepatol; 1999 Oct; 31(4):598-603. PubMed ID: 10551381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hepatitis C virus-associated mixed cryoglobulinemia after liver transplantation.
    Abrahamian GA; Cosimi AB; Farrell ML; Schoenfeld DA; Chung RT; Pascual M
    Liver Transpl; 2000 Mar; 6(2):185-90. PubMed ID: 10719018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Mixed Cryoglobulinemia Despite Sustained Virologic Response to Treatment: A Case Report.
    Chowdhury R; Tsen A
    Am J Kidney Dis; 2017 Aug; 70(2):301-304. PubMed ID: 28343737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia.
    Calleja JL; Albillos A; Moreno-Otero R; Rossi I; Cacho G; Domper F; Yebra M; Escartín P
    Aliment Pharmacol Ther; 1999 Sep; 13(9):1179-86. PubMed ID: 10468699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
    Gragnani L; Fognani E; Piluso A; Boldrini B; Urraro T; Fabbrizzi A; Stasi C; Ranieri J; Monti M; Arena U; Iannacone C; Laffi G; Zignego AL;
    Hepatology; 2015 Apr; 61(4):1145-53. PubMed ID: 25431357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3.
    Belperio PS; Shahoumian TA; Loomis TP; Mole LA; Backus LI
    J Hepatol; 2019 Jan; 70(1):15-23. PubMed ID: 30266283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoglobulinemia is an independent factor negatively associated with sustained virological response in chronic hepatitis C patients.
    Fan XH; Wu CH; Wang LF; Zheng YY; Yao Y; Lu HY; Xu XY; Wei L
    Chin Med J (Engl); 2012 Nov; 125(22):4014-7. PubMed ID: 23158135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
    Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HCV-RNA detection using different PCR methods in sera, cryoglobulins and peripheral blood mononuclear cells of patients with mixed cryoglobulinemia.
    de Maddalena C; Zehender G; Bianchi Bosisio A; Monti G; Monteverde A; Invernizzi F; Galli M
    Clin Exp Rheumatol; 1995; 13 Suppl 13():S119-22. PubMed ID: 8730491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Occult Hepatitis C Virus Infection in Egyptian Patients Who Achieved a Sustained Virologic Response to Direct-Acting Antiviral Agents.
    Mashaal AR; Abd El-Hameed M; El Ray AA; Mahmoud Diab T; Dawood RM; Shemis MA; Seyam M
    Asian Pac J Cancer Prev; 2022 Sep; 23(9):2965-2971. PubMed ID: 36172658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.